Record Details

Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial

Harvard Dataverse (Africa Rice Center, Bioversity International, CCAFS, CIAT, IFPRI, IRRI and WorldFish)

View Archive Info
 
 
Field Value
 
Title Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial
 
Identifier https://doi.org/10.7910/DVN/EQJPZT
 
Creator Cohen, Jessica
Dupas, Pascaline
Schaner, Simone
 
Publisher Harvard Dataverse
 
Description Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one run the risk of increasing the other. Using rich experimental data on household treatment-seeking behavior in Kenya, we study the implications of this tradeoff for subsidizing life-saving antimalarials sold over-the-counter at retail drug outlets. We show that a very high subsidy (such as the one under consideration by the international community) dramatically increases access, but nearly half of subsidized pills go to patients without malaria. We study two ways to better target subsidized drugs: reducing the subsidy level and introducing rapid malaria tests over-the-counter.
 
Subject Medicine, Health and Life Sciences
Social Sciences
Health
Government policy
Regulation
Public health
Economic development
Malaria
Product pricing
Technology adoption
 
Language English
 
Contributor Research Support, Innovations for Poverty Action
 
Type Survey data
Administrative data